Sinclair IS Pharma to focus on aesthetics

26 November 2015 - Deborah Wilkes

Archived

Sinclair IS Pharma will become a "pure-play aesthetics company" following the disposal of its non-aesthetics business to Alliance Pharma in a deal worth £132 million (US$199 million). The company says a "number of strategic options for the aesthetics business remain".

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: